LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma

TOKYO, July 29, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its in-house discovered tyrosine kinase inhibitor, “LENVIMA®” (generic name: lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial chemoembolization (TACE) has been approved by the National…

maxWin Receives Honesty Award 2025, Setting New Standards for Integrity in Online Gaming

KUALA LUMPUR, MALAYSIA – July 25, 2025 – (SeaPRwire) – maxWin (https://maxwinofficial.com), a leading name in Asia’s digital gaming landscape, has secured the prestigious Honesty Award 2025, cementing its status as a standard-bearer for trust, integrity, and ethical conduct in the online entertainment industry. The Honesty Award, bestowed upon brands that consistently prioritize transparent operations…

KELESI Showcases Micron-Level Innovative Materials at ARCHIDEX 2025, Expands Strategic Presence in Southeast Asia

Kuala Lumpur, July 23, 2025 — At the 24th International Architecture, Interior Design & Building Exhibition Malaysia (ARCHIDEX 2025), KELESI New Material Technology Co., Ltd., a professional Chinese manufacturer of acrylic solid surface materials, made a prominent appearance with its full product matrix and latest innovations. This exhibition not only serves…

Prototype divertor outer vertical target for the ITER fusion experimental reactor is completed and the sample has passed the ITER Organization’s certification test

- Rationalization of domestic production technologies and strengthening of the system in Japan for manufacturing divertor outer vertical targets for ITER- Seeking to contribute to the ITER Project and provide components for the prototype reactor for fusion energy and startup machinesTOKYO, July 23, 2025 - (JCN Newswire via SeaPRwire.com) -…

Launch of Beova(R) Tablets in Thailand for Overactive Bladder

TOKYO, July 23, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and KYORIN Pharmaceutical Co., Ltd.(Headquarters: Chiyoda-ku, Tokyo, President and CEO: Yutaka Ogihara, “KYORIN”) announced today that Eisai (Thailand) Marketing Co., Ltd. (“Eisai Thailand”), a subsidiary of Eisai, has launched overactive bladder treatment…

Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support

SAN DIEGO, July 23, 2025 - (JCN Newswire via SeaPRwire.com) - Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, announced today that its San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This significant…

Mitsubishi Motors to Terminate Its Joint Venture Partnership with Shenyang Aerospace Mitsubishi Motors Engine Manufacturing

TOKYO, July 22, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced the termination of its engine business operation at Shenyang Aerospace Mitsubishi Motors Engine Manufacturing Co., Ltd. (hereinafter, SAME) in China and has terminated the joint venture partnership.Established in August 1997, SAME began engine…

Eisai To Present Four-Year Efficacy And Safety Data On Continuous Treatment With Lecanemab At The Alzheimer’s Association International Conference 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab longterm data, an immunoassay for measuring amyloid-B protofibrils in cerebrospinal fluid, and asubcutaneousl form of lecanemab for continued treatment of ADAD is a progressive, relentless disease caused by a continuous underlying neurotoxic process that begins before and…

Sapient Intelligence Open-Sources Hierarchical Reasoning Model, a Brain-Inspired Architecture that Solves Complex Reasoning Tasks with 27 Million Parameters

SINGAPORE, JULY 21, 2025 - (ACN Newswire via SeaPRwire.com) - AGI research company Sapient Intelligence today announced the open-source release of its Hierarchical Reasoning Model (HRM), a brain-inspired architecture that leverages hierarchical structure and multi-timescale processing to achieve substantial computational depth without sacrificing training stability or efficiency. Trained on just…

S.BIOMEDICS Cell Therapy for Parkinson’s Disease Shows Positive Data from Its Phase 1/2a Clinical Trial

Seoul, South Korea – July 21, 2025 – (SeaPRwire) – S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell therapy for Parkinson’s disease. The data demonstrate a favorable safety and efficacy profile of A9-DPC in 12 participants at 12 months compared to baseline. Participants were divided equally into a low-dose…

StealthMole Joins Netskope Technology Partner Program to Deliver Deep and Dark Web Threat Intelligence Integration

Singapore – July 21, 2025 – (SeaPRwire) – StealthMole, a rising player in cyber threat intelligence, has officially joined the Netskope Technology Partner Program, bringing a new layer of visibility into deep and dark web activity through a recently launched integration on the Netskope Cloud Exchange platform. The integration – StealthMole CRE –…